CSS
SANA icon

Cubist Systematic Strategies’s Sana Biotechnology SANA Stock Holding History

Cubist Systematic Strategies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46,653
Closed -$194K – 3496
2024
Q3 		$194K Buy
+46,653
New +$245K ﹤0.01% 2580
2023
Q2 		– Sell
-20,294
Closed -$66.4K – 4203
2023
Q1 		$66.4K Sell
20,294
-78,879
-80% -$315K ﹤0.01% 3522
2022
Q4 		$392K Sell
99,173
-86,821
-47% -$425K ﹤0.01% 3185
2022
Q3 		$1.12M Buy
185,994
+157,501
+553% +$1.14M 0.01% 2533
2022
Q2 		$183K Sell
28,493
-25,483
-47% -$162K ﹤0.01% 3749
2022
Q1 		$446K Buy
53,976
+40,476
+300% +$327K ﹤0.01% 2610
2021
Q4 		$209K Buy
+13,500
New +$260K ﹤0.01% 3010

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cubist Systematic Strategies's SANA Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Sana Biotechnology (SANA) in Q4 2024, closing a stake of 46,653 shares — an estimated $194K sold.

Cubist Systematic Strategies first reported a position in SANA in Q4 2021 and held it in 7 quarters. The position peaked at $1.12M in Q3 2022. 164 funds tracked by Wall St. Rank hold SANA as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Sana Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 46,653 Sana Biotechnology shares in Q4 2024, an estimated $194K.
  • Cubist Systematic Strategies first reported a position in Sana Biotechnology in Q4 2021 and held it in 7 quarters.
  • Cubist Systematic Strategies's Sana Biotechnology position peaked at $1.12M in Q3 2022.
  • 164 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.